Tygacil Injection IP 50 Mg – Injectable Strength for Unbeatable Infections.
TIGORT Injection: Tigecycline 50 mg/vial (Cake Form)is a glycylcycline antibiotic primarily used to combat bacterial infections such as respiratory infections, complicated intra-abdominal infections, and skin infections.
Tigecycline has broad-spectrum bacteriostatic activity by binding to the 30S ribosomal subunit of bacteria and preventing the synthesis of protein required for bacterial cell growth, further stopping the growth of bacteria.
Recommended By Specialists:
Infectious Disease Specialists – It should mainly be used to prefer the combination for Multidrug-resistant infections (e.g., MRSA, VRE, ESBL-producing organisms)
Pulmonologists: It should be used to prefer to treat the disease for drug-resistant lower respiratory tract infections
Critical Care: It should be mainly used to prefer to treat Severe infections or intra-abdominal infections
Key Benefits of Tygacil Injection IP 50 Mg – TIGORT Injection
Broadest Spectrum among Tetracyclines: Effective against multidrug-resistant (MDR) pathogens, including MRSA, VRE, ESBL-producing organisms, and Acinetobacter.
Bacteriostatic Action with High Tissue Penetration: Excellent tissue distribution, especially in skin, lungs, and intra-abdominal sites, and the Injectable form ensures higher bioavailability.
No Cross-Resistance with β-lactams or Fluoroquinolones: Effective against Difficult-to-Treat Infections where traditional antibiotics are ineffective, especially in polymicrobial and resistant infections.
INDICATIONS:
Complicated Intra-Abdominal Infections (cIAIs)
Skin and Skin Structure Infections (cSSSIs)
Community-Acquired Bacterial Pneumonia (CAP)